From the bench to the bedside: mesenchymal stromal cells as immunoregulatory and regenerative therapies
BackgroundMesenchymal stromal cells (MSCs) have emerged as one of the most extensively studied adult stem cell populations, celebrated for their self-renewal, multilineage differentiation potential, and remarkable immunomodulatory properties.